AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.680
-0.020 (-0.74%)
Dec 20, 2024, 4:00 PM EST - Market closed
AC Immune Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for AC Immune stock have an average target of 12, with a low estimate of 8.00 and a high estimate of 16. The average target predicts an increase of 347.76% from the current stock price of 2.68.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 15, 2024.
Analyst Ratings
The average analyst rating for AC Immune stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +497.01% | Nov 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +497.01% | Nov 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +497.01% | Sep 18, 2024 |
| BTIG | BTIG | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +198.51% | May 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +497.01% | Mar 15, 2024 |
Financial Forecast
Revenue This Year
27.43M
from 14.80M
Increased by 85.33%
Revenue Next Year
49.56M
from 27.43M
Increased by 80.69%
EPS This Year
-0.54
from -0.64
EPS Next Year
-0.40
from -0.54
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 28.6M | 147.8M | 178.8M | |||
| Avg | 27.4M | 49.6M | 103.0M | |||
| Low | 26.0M | n/a | 31.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 93.5% | 438.9% | 260.7% | |||
| Avg | 85.3% | 80.7% | 107.8% | |||
| Low | 75.5% | - | -37.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -0.54 | 0.37 | 0.68 | |||
| Avg | -0.54 | -0.40 | -0.25 | |||
| Low | -0.53 | -0.75 | -0.86 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.